[DPHARMA] QoQ Annualized Quarter Result on 31-Dec-2018 [#4]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-Feb-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
31-Dec-2018 [#4]
Profit Trend
QoQ- 7.39%
YoY- 12.12%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Revenue 584,942 591,704 601,544 498,722 510,784 514,500 533,036 6.38%
PBT 75,826 74,204 75,144 59,666 56,010 52,340 53,020 26.90%
Tax -18,173 -17,442 -17,284 -12,025 -11,648 -10,368 -10,432 44.73%
NP 57,653 56,762 57,860 47,641 44,362 41,972 42,588 22.35%
-
NP to SH 57,653 56,762 57,860 47,641 44,362 41,972 43,128 21.32%
-
Tax Rate 23.97% 23.51% 23.00% 20.15% 20.80% 19.81% 19.68% -
Total Cost 527,289 534,942 543,684 451,081 466,421 472,528 490,448 4.94%
-
Net Worth 505,919 503,029 496,410 483,173 501,487 209,983 206,429 81.67%
Dividend
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Div 8,994 13,237 - 36,403 13,197 8,399 - -
Div Payout % 15.60% 23.32% - 76.41% 29.75% 20.01% - -
Equity
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Net Worth 505,919 503,029 496,410 483,173 501,487 209,983 206,429 81.67%
NOSH 680,106 661,881 661,881 661,881 661,881 650,902 278,959 81.04%
Ratio Analysis
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
NP Margin 9.86% 9.59% 9.62% 9.55% 8.69% 8.16% 7.99% -
ROE 11.40% 11.28% 11.66% 9.86% 8.85% 19.99% 20.89% -
Per Share
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 86.71 89.40 90.88 75.35 77.41 183.76 191.08 -40.91%
EPS 8.65 8.52 8.76 7.26 6.79 6.44 15.28 -31.54%
DPS 1.33 2.00 0.00 5.50 2.00 3.00 0.00 -
NAPS 0.75 0.76 0.75 0.73 0.76 0.75 0.74 0.89%
Adjusted Per Share Value based on latest NOSH - 661,881
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
RPS 60.81 61.51 62.53 51.85 53.10 53.49 55.41 6.38%
EPS 5.99 5.90 6.01 4.95 4.61 4.36 4.48 21.34%
DPS 0.93 1.38 0.00 3.78 1.37 0.87 0.00 -
NAPS 0.5259 0.5229 0.5161 0.5023 0.5213 0.2183 0.2146 81.66%
Price Multiplier on Financial Quarter End Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 30/09/19 28/06/19 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 -
Price 1.40 1.37 1.28 0.95 1.23 1.30 2.80 -
P/RPS 1.61 1.53 1.41 1.26 1.59 0.71 1.47 6.24%
P/EPS 16.38 15.98 14.64 13.20 18.30 8.67 18.11 -6.46%
EY 6.10 6.26 6.83 7.58 5.47 11.53 5.52 6.88%
DY 0.95 1.46 0.00 5.79 1.63 2.31 0.00 -
P/NAPS 1.87 1.80 1.71 1.30 1.62 1.73 3.78 -37.42%
Price Multiplier on Announcement Date
30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 CAGR
Date 29/11/19 30/08/19 21/05/19 18/02/19 28/11/18 26/11/18 28/05/18 -
Price 1.39 1.41 1.36 1.03 1.07 1.08 3.35 -
P/RPS 1.60 1.58 1.50 1.37 1.38 0.59 1.75 -5.79%
P/EPS 16.26 16.44 15.56 14.31 15.92 7.20 21.67 -17.41%
EY 6.15 6.08 6.43 6.99 6.28 13.88 4.62 20.98%
DY 0.96 1.42 0.00 5.34 1.87 2.78 0.00 -
P/NAPS 1.85 1.86 1.81 1.41 1.41 1.44 4.53 -44.92%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment